Nucleus Network Acquires Hammersmith Medicines Research
BRISBANE, Australia & LONDON — Nucleus Network, a global leader in early phase clinical research, today announced the acquisition of Hammersmith Medicines Research (HMR), one of the United Kingdom's most respected early phase clinical trial organisations. This milestone marks a significant step in Nucleus Network's global growth, establishing the only early phase provider with dedicated facilities in Australia, the United States, and the United Kingdom.
Article content
The acquisition brings together two organisations with a shared mission: advancing medicine and improving lives. It also honours the legacy of Dr Malcolm Boyce, whose leadership established HMR as a centre of excellence in early phase research across the UK and Europe. With complementary scientific expertise and a strong, mutual commitment to participant safety and ethical conduct, the combined organisation is well positioned to accelerate clinical development and deliver inclusive, high-quality studies across three continents.
Article content
'We are deeply honoured by the trust Dr Boyce has placed in us to carry forward HMR's legacy,' said
Article content
. 'This acquisition is about more than expanding our global footprint. It reflects a genuine alignment of values, culture, and purpose. Together, we are building a platform that will help redefine the way early phase trials are delivered.'
Article content
A New Standard for Early-Phase Clinical Trials
Article content
With the acquisition of HMR, Nucleus Network is setting a new global benchmark in the delivery of early-phase clinical trials. Sponsors now benefit from a fully integrated model that combines global reach with deep local expertise. By harnessing the strength of our globally leading and multi-jurisdictional business development team, we will work in close partnership with sponsors to guide trials to the geographic locations that best align with their strategic priorities. Studies can commence in one regulatory environment and seamlessly transition to another, enabled by harmonised processes and consistently high-quality standards, accelerating timelines and reducing operational risk.
Article content
The expanded geographic footprint expands access to broader and more diverse volunteer and patient populations. This scale supports faster recruitment and more inclusive study designs, both of which are critical for first-in-human and adaptive trial protocols. HMR's decades of scientific and operational excellence complement Nucleus Network's advanced infrastructure and digital capabilities. Together, they bring added precision to study execution and data quality, driving robust outcomes across all sites.
Article content
Sponsors will experience more streamlined engagement through unified systems, shared best practices, and coordinated project delivery, simplifying the complexities of early-phase trial execution. This integration further strengthens Nucleus Network's position as the most experienced global provider dedicated to early-phase clinical research.
Article content
At the same time, Nucleus Network will continue to partner with CROs around the world, offering flexible services that complement existing partnerships and extend reach across geographies.
Article content
' This acquisition expands what's possible for our sponsors,' Pisarev added. 'It deepens our scientific capabilities, strengthens our operational reach, and reinforces our commitment to delivering life-changing therapies to patients around the world.' Nucleus Network will continue to operate its clinical sites in Brisbane, Melbourne, and Sydney (from ~2026), Australia; Minneapolis, Minnesota; and London, England, ensuring continuity for ongoing studies and trusted relationships.
Article content
Nucleus Network is the only early-phase clinical research provider with a global footprint, operating dedicated Phase I facilities in Australia, the United States, and the United Kingdom. With over 20 years of experience and more than 1,500 first-in-human studies conducted, Nucleus Network is recognized for its scientific excellence, operational integrity, and commitment to innovation.
Article content
Article content
Article content
Article content
Contacts
Article content
Media Contact
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
Nick Wodeshick From The Crypto Content Hub Produces Article About Tariff-Proofing Your Portfolio with Protected Bitcoin ETFs
New York, New York--(Newsfile Corp. - August 15, 2025) - Nick Wodeshick, an expert contributor for VettaFi's Crypto Content Hub, has announced the publication of their latest article, focused on showing how with more bitcoin mining rig manufacturers moving to the United States, bitcoin may be less at risk from tariffs than previously expected. Help Tariff-Proof Your Portfolio With Protected Bitcoin ETFs Even though crypto trading is banned in China, many China companies are still tied to the bitcoin ecosystem. This includes companies that produce machines used to mine bitcoin. As such, severe tariffs between the U.S. and China could have a noticeable effect on the bitcoin supply chain. For investors counting on bitcoin's tariff resiliency, it may be best to do so in a risk-managed manner. To view the full article, please visit About the Crypto Content Hub Sponsored by Calamos The Crypto Content Hub, a dedicated segment of ETF Trends, is your premier destination for news, insights, and analysis on crypto-related content, often tied to Calamos Investments. This channel offers in-depth coverage of crypto ETF space, highlighting new product launches, market trends, investment strategies, and expert commentary. Whether you're an investor seeking to understand cryptocurrency in an ETF format or a financial professional staying informed on industry innovations, the Crypto Content Hub provides essential resources to navigate this dynamic segment of the market. About VettaFi VettaFi is a leading provider of data-driven insights and specialized services for asset managers and investors, bringing together a wealth of expertise to support client success. At the core of VettaFi is a commitment to fostering strong relationships and delivering innovative solutions that help clients engage, grow, and thrive in an increasingly complex financial landscape. For more information about VettaFi, please visit
CTV News
3 hours ago
- CTV News
Blackstone-backed Legence files for U.S. IPO
Engineering and maintenance service provider Legence, which is backed by the world's largest alternative asset manager Blackstone, said on Friday it had filed for an initial public offering in the United States. Engineering and maintenance service provider Legence, which is backed by the world's largest alternative asset manager Blackstone, said on Friday it had filed for an initial public offering in the United States. The terms of the proposed public offering were not disclosed. The U.S. IPO market has seen a resurgence in activity with a flurry of companies coming forward to list their shares to tap growing investor confidence, after a slowdown in April due to trade policy changes. Transit-tech firm Via also publicly filed to go public in New York on Friday. Shares of cryptocurrency exchange Bullish more than doubled in their New York debut earlier in the week, while space tech firm Firefly Aerospace also received a blockbuster response earlier in the month. In 2020, Blackstone acquired Legence from private equity firm Gemspring Capital. Before the deal, the company was known as Therma Holdings. The San Jose, Calif.-based company offers services for the built environment, including sustainability, consulting and green construction, helping clients reduce operating costs and carbon emissions. Over the years, Legence has bulked up through acquisitions of rivals such as Corporate Sustainability Strategies, P2S, A.O. Reed and OCI Associates. Blackstone last month said it is preparing more companies to go public than any other time since the record IPO year of 2021. Goldman Sachs and Jefferies are the lead book-running managers for the offering. The company intends to list its shares on Nasdaq under the ticker symbol 'LGN.' (Reporting by Arasu Kannagi Basil and Pritam Biswas in Bengaluru; Editing by Vijay Kishore)
Globe and Mail
4 hours ago
- Globe and Mail
From Tradition to Trend: Chinese Confinement Nannies Gain Popularity Across the U.S.
"A Chinese confinement nanny in her 50s gently holds a Chinese-American newborn in a modern living room. This is the currently growing trend of traditional postpartum care in the United States" The centuries-old tradition of Chinese postpartum confinement is going mainstream in America, as more families seek culturally rooted newborn care and maternal recovery support. LOS ANGELES, CA - August 15, 2025 - The centuries-old practice of zuo yue zi — or Chinese postpartum confinement — is no longer limited to the Asian community. Families across the United States are increasingly hiring Chinese confinement nannies to ensure mothers receive proper rest, nutrition, and newborn care during the critical first 30 to 100 days after birth. 'Postpartum care is about more than changing diapers — it's about a mother's physical healing, emotional stability, and family bonding,' said Stephanie Lin, founder of My Asian Nanny. 'We've seen a 40% increase in inquiries from non-Asian families over the past three years, especially in major metro areas.' The growing interest reflects a wider shift in attitudes toward postpartum recovery, as more parents seek holistic and culturally informed support. Confinement nannies typically provide round-the-clock newborn care, traditional healing meals, lactation support, and gentle postpartum exercises to aid recovery. The trend is supported by research showing that mothers who receive consistent postpartum care report faster physical recovery, lower stress levels, and a reduced risk of postpartum depression. Parents can learn more or request a nanny by completing the Family Registration Intake Form. About My Asian Nanny My Asian Nanny is a U.S.-based referral agency specializing in postpartum confinement nannies and newborn care. Serving families nationwide, the agency connects clients with experienced caregivers who provide round-the-clock support, traditional postpartum meals, and expert newborn handling. Media Contact Company Name: My Asian Nanny Contact Person: Stephanie Lin Email: Send Email Phone: 6269887577 Address: 216 west Garvey Avenue Unit G City: Monterey Park State: CA Country: United States Website:
